Skip to main content

Table 1 Baseline characteristics for 447 patients whose status at the end of the study period is known

From: Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts

Baseline characteristic/Outcome

Total (N = 447) n, %

Months on effective regimen (mean, sd)

11.6 (7.9)

Ever on effective regimen

369 (82.6)

Sociodemographic characteristics

 Age, years (mean, sd)

35.9 (11.4)

 Female sex

84 (18.8)

 Married (n = 434)

200 (46.1)

 Unemployed (n = 445)

352 (79.1)

 Current or previous incarceration

237 (53.0)

 Alcohol abuse/dependence

194 (43.4)

 Illicit drug use

79 (17.7)

 Homelessness

16 (3.6)

Comorbidities

 HIV-positive (n = 446)

3 (0.7)

 Diabetes mellitus (n = 446)

18 (4.0)

 Comorbid condition

322 (72.0)

Prior TB treatment exposure

 Previously treated for TB

444 (99.3)

 History of prior injectable exposure (n = 436)

145 (33.3)

 History of prior fluoroquinolone exposure (n = 436)

69 (15.8)

 History of prior default

16 (3.6)

 Number of previous TB treatments (mean, sd)

2.1 (1.2)

 > 2 previous TB treatment (n = 436)

141 (32.3)

Clinical indications of disease severity

 Bilateral and cavitary disease on baseline chest x-ray (n = 443)

278 (62.8)

 Severe pulmonary disease on baseline chest x-ray

195 (43.6)

 Low BMI at start of treatment (n = 446)

190 (42.6)

 Severe baseline clinical status

277 (62.0)

 Extrapulmonary disease (n = 381)

39 (10.2)

 Previous TB-related surgery (n = 445)

50 (11.2)

 Baseline XDR-TB

22 (4.9)

Initial treatment outcome

 Successful

299 (66.9)

 Cure

280 (62.6)

 Treatment Completion

19 (4.3)

 Unsuccessful

148 (33.1)

 Death

30 (6.7)

 Treatment Failure

39 (8.7)

 Default

78 (17.4)

 Transfer Out

1 (0.2)